Each year, the FDA approves far fewer health technologies for use in children than adults. This disparity extends to pregnant moms as well. As a result, doctors don’t have access to the latest innovations when caring for their youngest and most vulnerable patients.
We’re thrilled that CobiCure, a nonprofit company that is part of the Advancium Health Network, is addressing this challenge in pediatric and maternal health. Following its mission to reimagine pediatric health care by supporting the development of innovative medical devices, CobiCure has generously funded a MedTech: CobiCure Fellow for Pediatric MedTech Innovation at Impact1. Part of the Stanford Mussallem Center for Biodesign, the Impact1 initiative is focused on advancing the development of health technologies for children and expectant moms.
The CobiCure fellow will perform market research, content design, prototyping, and testing to eventually bring a new medical device or technology to market.
“This fellow will not only improve clinical care for children and moms but will also help us grow the field of pediatric and maternal medical device innovation,” says Janene H. Fuerch, MD, co-director of Impact1 and assistant director of the Biodesign Innovation Fellowship Program.
Thank you, CobiCure, for improving care for children and moms at Lucile Packard Children’s Hospital Stanford and beyond!
This article originally appeared in the Fall 2024 issue of the Packard Children’s News.